Physiological and pathological roles of inflammasomes in wound healing
5 affiliations
- 1POLYMAT, Applied Chemistry Department, University of the Basque Country (UPV/EHU), Donostia, San Sebastián, 20018, Spain
- 2Department of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran
- 3Student Research Committee, Mazandaran University of Medical Sciences, Babol, Iran
- 4Department of Dermatology, School of Medicine, University of California Davis, Sacramento, CA, 95817, USA
- 5Burn Research Center, Iran University of Medical Sciences, Tehran, Iran; Department of Plastic and Reconstructive Surgery, Hazrat Fatemeh Hospital, Iran University of Medical Sciences, Tehran, Iran; Corresponding author at: Burn Research Center, Iran University of Medical Sciences, Tehran, Iran.
Abstract
Wound healing is a dynamic, tightly regulated process involving hemostasis, inflammation, proliferation, and remodeling. Effective progression through these phases requires coordinated activation and resolution of innate immune responses. Inflammasomes—multiprotein platforms that sense cellular stress and microbial products—have emerged as crucial regulators of sterile inflammation during tissue repair. Canonical inflammasomes such as NLRP3, NLRC4, and AIM2 promote maturation of interleukin-1β and interleukin-18, and trigger pyroptotic cell death, orchestrating the inflammatory milieu required for early healing. However, dysregulated or persistent inflammasome activation contributes to pathological inflammation, tissue damage, and impaired healing, especially in diabetic wounds and chronic ulcers. Hyperglycemia-driven oxidative stress, impaired autophagy, and aberrant macrophage polarization amplify inflammasome activity, perpetuating non-resolving inflammation. In parallel, chronic wound pathogens like Pseudomonas aeruginosa can subvert inflammasome responses—via effectors such as ExoT that inhibit Crk/Abl signaling and dampen NLRC4 activation—promoting persistent infection. This review integrates current evidence on the physiological and pathological roles of inflammasomes in wound healing, highlighting mechanisms of their dysregulation in diabetic and chronic wounds. We also discuss emerging therapeutic strategies, including selective inflammasome inhibitors, antioxidants, autophagy inducers, and novel biomaterials that locally modulate inflammasome activity. Understanding the dual role of inflammasomes and their context-dependent regulation could enable targeted interventions to restore balanced inflammation and accelerate wound repair.
Related
- Roles and Mechanisms of Inflammasomes in Aging and Age-related Diseases
- Suppressed Paracrine Signaling of Cystatin a from Keratinocytes to Fibroblasts and Endotheliocytes Delays Wound Healing in Diabetes
- Mechanical regulation of LINC complex function: structural basis, physiological roles, and disease mechanisms in transnuclear mechanotransduction
- An Enzyme-DNA Nanostructure with Enhanced Catalysis Accelerates MRSA Wound Healing
- Enhancing Exosome Production from Adipose-Derived Stem Cells via Arachidonic Acid Priming for Diabetic Wound Healing
BibTeX
@article{momeny2026physiological,
title = {{Physiological and pathological roles of inflammasomes in wound healing}},
author = {Mohammadamin Momeny and Parsa Pashaei and Amirreza Hafezi and Sepideh Hashemi and Sasha H. Shafikhani and Sanaz Alizadeh and Massoud Vosough},
journal = {Advances in Redox Research},
year = {2026},
month = oct,
doi = {10.1016/j.arres.2026.100208},
url = {https://doi.org/10.1016/j.arres.2026.100208},
note = {CC BY},
}
RIS
TY - JOUR
TI - Physiological and pathological roles of inflammasomes in wound healing
AU - Mohammadamin Momeny
AU - Parsa Pashaei
AU - Amirreza Hafezi
AU - Sepideh Hashemi
AU - Sasha H. Shafikhani
AU - Sanaz Alizadeh
AU - Massoud Vosough
PY - 2026
DA - 2026/10/30
JO - Advances in Redox Research
DO - 10.1016/j.arres.2026.100208
UR - https://doi.org/10.1016/j.arres.2026.100208
AB - Wound healing is a dynamic, tightly regulated process involving hemostasis, inflammation, proliferation, and remodeling. Effective progression through these phases requires coordinated activation and resolution of innate immune responses. Inflammasomes—multiprotein platforms that sense cellular stress and microbial products—have emerged as crucial regulators of sterile inflammation during tissue repair. Canonical inflammasomes such as NLRP3, NLRC4, and AIM2 promote maturation of interleukin-1β and interleukin-18, and trigger pyroptotic cell death, orchestrating the inflammatory milieu required for early healing. However, dysregulated or persistent inflammasome activation contributes to pathological inflammation, tissue damage, and impaired healing, especially in diabetic wounds and chronic ulcers. Hyperglycemia-driven oxidative stress, impaired autophagy, and aberrant macrophage polarization amplify inflammasome activity, perpetuating non-resolving inflammation. In parallel, chronic wound pathogens like Pseudomonas aeruginosa can subvert inflammasome responses—via effectors such as ExoT that inhibit Crk/Abl signaling and dampen NLRC4 activation—promoting persistent infection. This review integrates current evidence on the physiological and pathological roles of inflammasomes in wound healing, highlighting mechanisms of their dysregulation in diabetic and chronic wounds. We also discuss emerging therapeutic strategies, including selective inflammasome inhibitors, antioxidants, autophagy inducers, and novel biomaterials that locally modulate inflammasome activity. Understanding the dual role of inflammasomes and their context-dependent regulation could enable targeted interventions to restore balanced inflammation and accelerate wound repair.
SN - 2667-1379
ER -